Skip to main content

Table 2 Differentially expressed miRNAs among mammary tumor subtypes

From: Integrated miRNA and mRNA expression profiling of mouse mammary tumor models identifies miRNA signatures associated with mammary tumor lineage

Tumor subtype

mmu-miRNA

Fold change

t-Test P-value

Chromosome

Basal

448

8.0

3.11E-14

X

 

201

7.2

7.48E-12

X

 

687

7.6

9.75E-12

14

 

463

7.2

1.05E-11

X

 

713

8.3

4.90E-11

13

 

490

9.6

7.22E-11

6

 

323

7.2

1.15E-10

12

 

137

7.1

1.35E-10

3

 

688

8.4

1.17E-09

15

 

302b*

9.2

1.58E-09

3

 

295

7.7

2.58E-09

7

 

592

7.0

4.08E-09

6

 

412

9.7

7.13E-08

12

 

681

7.2

8.24E-08

12

 

464

7.5

1.59E-07

15

 

718

8.0

2.05E-07

X

 

217

7.6

2.52E-07

11

 

465a-5p

8.6

2.82E-07

X

 

701

8.7

4.95E-07

5

 

693-5p

11.0

1.43E-06

17

Luminal

106a

10.8

1.21E-15

X

 

106b

12.2

6.70E-15

5

 

805

12.4

2.10E-14

MT

 

191

9.9

9.20E-12

9

 

30c

14.4

4.19E-11

4

 

26a

12.6

5.51E-11

9

 

19b

15.7

1.11E-10

X

 

30b

13.7

2.80E-10

15

 

30a

13.4

3.23E-10

1

 

30d

10.4

4.64E-10

15

 

146b

17.6

7.42E-10

19

 

148a

18.6

1.35E-09

6

 

193

13.1

2.78E-09

11

 

141

20.9

2.95E-09

6

 

195

14.8

3.25E-09

11

 

26b

15.1

1.16E-07

1

 

200a

13.4

6.03E-07

4

 

182

13.2

8.78E-06

6

 

30e

9.8

1.46E-05

4

 

200b

13.8

2.38E-03

4

  1. The highly expressed top 20 miRNAs that are associated with either basal-like or luminal-type mammary tumors. mmu-miR-302b* designated in the miR9.0 release is currently named mmu-miR-302b in the miR17.0 release, but the sequence has not changed [54].